chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Client verbalized dizziness after receiving  the vaccine.  Client was evaluated by Fire Rescue. According to Paramedics no additional assessments needed and client was released to go home at 4:25 pm after symptom resolved.
In April 1999, the pt received his first injection of Lymerix and after the injection. he felt very achy which laster about a day. He experienced the same symptoms after the 2nd shot (injection date not provided). Then 2 weeks later, his symptoms returned and "have lasted". It was noted that he found a tick on himself prior to the 2nd injection. The most recent information received on 2/17/2000, indicates the outcome of the symptoms as ongoing. Additional information has been requested.
This spontaneous report was received from a medical assistant, and refers to a patient of unknown age and gender. No pertinent medical history, drug reactions, allergies or concurrent conditions were reported. On 08-DEC-2016 the patient was vaccinated with an improperly stored dose of PROQUAD for prophylaxis (dose and route of administration were not reported; lot # M022402, expiry 01-NOV-2017). No other suspect and concomitant medications were provided. On unspecified dates, the administered dose of vaccine experienced the temperature excursion of -12 degrees Celsius for 3 hours 43 minutes, and second excursion of -10 degrees Celsius for 7 hours 38 minutes. A digital data logger was involved. There had been no previous temperature excursions. There was no adverse effect reported. No product quality complaint was involved. Additional information has been requested.
Severe stomach pain; Cramping; Gas; Bloating; Rectal irritation and pain; Rectal irritation and pain; Headache; Diarrhea; This is a spontaneous report from a contactable consumer (patient). This is the first of two reports. A 52-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208), via an unspecified route of administration in left arm on 15Mar2021 at 12:15 (at the age of 52-years-old) as single dose for covid-19 immunization. Medical history included small intestinal bacterial overgrowth (SIBO), irritable bowel syndrome (IBS), fruit allergy (tomatoes) and allergic to spices (chili peppers) all from an unknown date and unknown if ongoing. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient had not been tested for covid-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included estradiol (ESTROGEN); hydroxyprogesterone caproate (PROGESTONE); pregnenolone (PREGNENOLONE) all taken for an unspecified indication, start and stop date were not reported. On 15Mar2021 at 16:00, the patient experienced severe stomach pain, cramping, gas, headache, diarrhoea, bloating, rectal irritation and pain. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of all the events was resolving at the time of report.   No follow-up attempts are needed. No further information is expected.
Administered the adjuvant only; Administered the adjuvant only; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 55-year-old male patient who received Herpes zoster (Shingrix) (batch number P39N2, expiry date 25th September 2023) for prophylaxis.   On 11th November 2022, the patient received Shingrix. On 11th November 2022, unknown after receiving Shingrix, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date: 11-Nov-2022 Reporter's comment: The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient was administered the Shingrix vaccine adjuvant without the active component, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
On December 4th at 3:00AM, I woke up with severe back pain that I can described as sever muscle spasms. I got a heating pad and took two Advil. I continued that treatment all that Saturday. When the pain didn't go away I went to the ER on Sunday. The doctor prescribed me with muscle relaxers and increased my Advil to 600mg. I continued that treatment. The pain had subsided. I eventually stopped taking the muscles relaxers and Advil. The following week the pain intensified. When I took a deep breath it felt like my back was seizing on my left side. The pain radiated from my left side. When I woke up on Wednesday on December 17th my stomach was bloated. I took two gas pills. That didn't relieve the bloating. I went to ER on December 15th. The doctors did some tests and they found out that I had a pleural effusion on my left lung which they thought was causing my pain. My pulmonologist had me do additional x-rays. He prescribed me a z-pak and cefuroxime 500mg 2xday for 7 days. I finished the z-pak yesterday. The back pain has started to subside. I have been low on energy. When I breathe in deep I can still feel pain in back but it is less intensified.
patient called clinic line to report "back of teeth starting bleeding on the same day" as her vaccination, happening  "within a matter of seconds" of the shot, admits to having poor dentition, but never bleeding of gums/teeth, referred to dentist or PCP, no other symptoms documented
Two weeks after the vaccine, patient had an unusually strong Myasthenia Gravis reaction. He was unable to shallow, choked on his food and violently vomited. Because of that, his doctor told him not to get the second dose.   SECOND POSSIBLE SIDE EFFECT:  Patient had left hip surgery on July 8th. On July 20th, he presented with low blood pressure. He usually has high blood pressure, hence, the BP RX. Lovelace Heart Hospital found a UTI and blood clots in both legs! He had no symptoms of the blood clots. (None in lungs) His doctors are stumped. Usually with blood clots the BP would be high, not low. He had no redness, no pain, no throbbing, no symptoms of blood clots. Also, his doctor said it is very rare to have clots in both legs. It is possible they were there before the surgery. He is still struggling with low BP and they can not determine why.
Severe fatigue, muscle pain, headache, nausea, diarrhea, violent shaking, and fever of 101. Symptoms subsided after 50 hours. My 37 year old biological son had similar reactions after his 2nd dose of the Moderna vaccine. We are both blood type A positive.
Sudden death 2/7/21 @ 0309 Started acute encephalopathy & required intubation Soon after intubation went into cardiac arrest Likely severe acidosis.
Extreme nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 16 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, manufacturer unknown), for Covid-19 Immunization. The following information was reported: NAUSEA (non-serious) with onset 2021, outcome "unknown", described as "Extreme nausea".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccine administered was expired 1/20/2022. Administered 1/21/2022.
Hives began  about 1 month after taking COVID vaccine. 1 x Daily Allegra seemed to alleviate sypmtoms - needed to take for 3 months daily. Eventually subsided however recently hives came back and sometimes Allegra will lessen hives however not fully alleviate the syptoms.
taking Paxlovid / covid right now; taking Paxlovid / covid right now; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team and product quality group. The reporter is the patient.  An 83-year-old female patient received BNT162b2 (BNT162B2), on 24Feb2021 as dose 1, single (Lot number: EN6200, Expiration Date: 30Jun2021) and on 25Mar2021 as dose 2, single (Lot number: EN6204, Expiration Date: Jun2021) at the age of 81 years, all intramuscular for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "taking Paxlovid / covid right now". The event "taking paxlovid / covid right now" required emergency room visit. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: It was reported that patient had covid right now and wants to treat it with Paxlovid, but she wants to know if this could cause a bad reaction in body. Caller is calling about the pills taken 3 in the morning 3 at night, Paxlovid. She is scared of the pill and doesn't know if will affect her or loose her words again. She knows there is so many things that can go wrong and she does take 3-4 other drugs. She asks is this drug going to hurt her to take Paxlovid.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300026462 Same patient, same product, different dose, different event;US-PFIZER INC-202300026488 Same patient, same product, different dose, different event;
Red itchy bumps on the palms of both hands and on the bottom of both feet was reported as worsened; red itchy bumps on the palms of both hands and on the bottom of both feet; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A 33 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 29Sep2021 (Lot number: 301458A) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU, administration date Sep2021. Vaccination history included: Bnt162b2 (First dose, LOT: EJ1686), administration date: 04Jan2021, when the patient was 32 years old, for COVID-19 Immunization, reaction(s): "none of these side effects after his previous 2 doses of the vaccine"; Bnt162b2 (Second dose, LOT: EN5318), administration date: 25Jan2021, when the patient was 32 years old, for COVID-19 Immunization, reaction(s): "none of these side effects after his previous 2 doses of the vaccine". The following information was reported: RASH PRURITIC (non-serious) with onset 29Sep2021, outcome "not recovered", described as "red itchy bumps on the palms of both hands and on the bottom of both feet"; CONDITION AGGRAVATED (non-serious) with onset 30Sep2021, outcome "not recovered", described as "Red itchy bumps on the palms of both hands and on the bottom of both feet was reported as worsened".  Additional information: Patient received his Pfizer BT Covid vaccine booster shot 2 days ago on 29Sep2021. Since the shot he was experiencing "red itchy bumps on the palms of both hands and on the bottom of both feet and red itchy bumps on palms of both hands was reported as worsened." The caller states he had none of these side effects after his previous 2 doses of the vaccine. Vaccination Facility Type was Pharmacy. AE(s) did not require a visit to Emergency Room or Physician Office. Patient had no AE(s) following prior vaccinations. Relevant Tests was none.  No follow-up attempts are possible. No further information is expected.
I premedicated prior to injection with benadryl 50mg po and otc pepcid. Approx 25 minutes post injection felt some very mild chest pressure that slowly developed to moderate pain scale 4 over a period of approx 2 hours then returned to a mild pressure once again, all left sided and no radiation of pain noted. At approx 430pm the pressure began to increase again and became painful at approx a 5 on the pain scale, it was then I developed diaphoresis,dizziness and severe nausea/vomitting., Bright green bile appearing vomitus. Went to ED where I was given IV,Zofran 4mg x 2 doses,Reglan 10mg IV and contiued go vomit violently. Recd prescriptions for antiemetic and dc home to ride out the vomitting.
Information has been received from a physician concerning a 12 year old female who received her first dose of GARDASIL on 14-AUG-2009 and second dose of 18-MAY-2010 respectively without incident. On 08-JAN-2011 the patient was vaccinated with her third dose of GARDASIL (dose not reported, lot # 1560Z, expiration date: 28-APR-2013). The patient was not pregnant. Concomitant therapy included vitamin b2 (riboflavin), MIDRIN, IMITREX, PHENERGAN, iron and nortriptyline. On 08-JAN-2011 the patient had a headache and treated it with nortriptyline, then she received her third dose of GARDASIL and passed out within minutes. The patient recovered within minutes without intervention. No treatment was given for the adverse event. The patient did not sought medical attention. Follow up information has been received from the physician concerning the 12 year old female patient with a history of migraine headache without treatment and headache at time of vaccination who on 08-JAN-2011 9:00 AM was vaccinated into right upper deltoid with the third dose of GARDASIL (Lot #1560Z). The patient fainted at the time of injection of GARDASIL, and recovered quickly on 08-JAN-2011. The patient continued to have headaches during that day. No further information is available.
Sore arm with dose #1 for a couple of days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 19Mar2021 07:45 (Lot number: EN6207) at the age of 73 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 19Mar2021 07:45, outcome "recovered" (Mar2021), described as "Sore arm with dose #1 for a couple of days". Therapeutic measures were not taken as a result of pain in extremity.  Additional information: Allergies to medications, food, or other products was none. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No other medications the patient received within 2 weeks of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.   No follow-up attempts are possible. No further information is expected.
PNEUMOVAX given 9/9/10. Redness, swelling, hot, pain in arm (upper) where shot was given. Treatment: MOTRIN, CLARITIN, KEFLEX.
Pt vaccinated on 9/14/10 & returned 9/16/10 with redness & swelling to left upper arm - 11x7 induration. No other symptoms reported. Tx - ice to area.
My arm and shoulder joint hurt. I had pain starting the evening of the shot and for a week or more, could barely move my upper arm. I continue to have restricted movement and a lot of pain, and some popping in my shoulder. It is especially bad at night when trying to sleep. It has been almost a month and my symptoms aren't much better.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 75-year-old female patient who received SHINGRIX (batch number L7SY9, expiry date 4th July 2021) for prophylaxis. On 28th March 2019, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 28th March 2019, less than a day after receiving SHINGRIX, the patient experienced injection site swelling (serious criteria clinically significant/intervention required), injection site pain (serious criteria clinically significant/intervention required) and injection site itching (serious criteria clinically significant/intervention required). The patient was treated with TYLENOL and medication unknown (Ice Pack (Nos)). On 3rd April 2019, the outcome of the injection site swelling, injection site pain and injection site itching were recovered/resolved. It was unknown if the reporter considered the injection site swelling, injection site pain and injection site itching to be related to SHINGRIX. Additional details were provoded as follows: The patient experienced injection site soreness, itching, and swelling (3 inch diameter) that started on the day of administration. The healtcare profession (HCP) reported that the patient treated herself with TYLENOL and ice and the symptoms were resolved on 3rd April 2019. The HCP consent to follow up.
Large local reaction 6 x 10cm of erythema, mild edema, and warmth at right upper thigh. Developed 24-48 hrs post DTaP injection).
Left side of chest  , muscles around my heart tightening  pressure , sharp pains  in intervals   started  09/08/2021  the sharp pains seemed to calm happening less frequently now 10/26/2021 ,
Severe headache, bilateral flank pain, severe muscle and joint paint, urgency, severe nausea no vomiting, blood pressure- 90/0, was unable to stand, extremely weak.
Pt recvd vax & 24 hrs p/2nd dose exp muscle skeletal pain & weakness & h/a;
Red papular rash appeared on forehead & spread to back of neck 30 min post vaccines given & lasted 48-72 hrs.
I got sick about 2 days later.  I had serve SOB with gasping for air. I could only take a few steps, then I would have to stop to catch my breath.  I went to the ER about this. I was diagnosis with Pneumonia.  They did x-ray, covid-19, and EKG.  Then I went home for a week, then it keep getting worst.  I then went back to the ER, they did a CT scan.  They gave me oxygen and I have been on it ever since.
Hives appeared above injection site of left thigh, spread up back and abdomen to the face. No tongue or throat swelling noted. Treated with benadryl. The next day pain in left leg and swelling from knee to hip noted twice the size of right leg. So far swelling lasting two days has not gone down yet.
1215 pm on 12/16/2020: pfizer covid vac in left arm Poor nights sleep with left arm pain at injection site 500am on 12/17/2020: stood up to get ready and immediately started to dizzy. Then immediately threw up and had darker green diarrhea. Once that finished I had the sweats and felt cold with a subjective fever until around 9 am with continued nausea. Symptoms resolved 11:40 AM.
1030-pt reported to staff that he was feeling a tightness in his throat. Pt reports that he dose have an allergy to bee stings. Pt was taken to the triage area for monitoring. Initial vital signs are HR 58 B/P 172/70 spO2 100% without oxygen supplementation. Pt denies having chest pain or shortness of breath. 1038-updated vital signs: HR 56 blood pressure 153/76, SpO2 100% on room air. After observation period pt declined transportation to the ED. Pt was advised to call 911 for any concerning symptoms. At the time pt left the observation area with his wife. Pt states that his symptoms were improved. Total time in triage area was 15 minutes for a total observation time of 30 minutes.
Dizziness/weakness post vacination. Refused transport, Medic assessed, PT was stabilized, symptoms improved, EKG and pulse ox, vitals normal
Mother described reaction as a local reaction to arm after vaccination--did not develop fever--did not seek medical care.
Information has been received from a woman in a physician's office concerning a 7 y/o male pt with  no allergies or medical history who on 17Mar1997 was vaccinated SC in the right thigh with a first dose of varicella virus vaccine live. Concomitant vaccination on the same day included a first doseSC in the left thigh of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). It was noted that the pt has right otitis media (ROM) at the time of vaccination and was put on "Amox". The reporter indicated that the mother called to report that the child was exposed to chickenpox and did not received the vaccine at one year of age. On 11Jul2003 the reporter noted that to date no other problems had been reported. Additional information has been requested.
Haven't had her period since getting the vaccine; Heart problems; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: AMENORRHOEA (non-serious), outcome "not recovered", described as "Haven't had her period since getting the vaccine"; CARDIAC DISORDER (non-serious), outcome "not recovered", described as "Heart problems".  Clinical course: Reporter stated she haven't had her period since getting the vaccine and is now having heart problems because of "your stupid vaccine".   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt received vaccine and they started to feel dizzy and then passed out in his chair momentarily. Pt began to feel better and then patient fainted again. Pt also complained of ringing in his ears. EMS was called to the bedside where they found patient to be hypotensive. Pt was resolved quickly. Once he began to feel better he was sat up at the side of the bed and monitored for a short while. Pt no longer had any symptoms or concerns and went home with his girlfriend
Sore arm; This is a spontaneous report from a contactable consumer (reported for herself). A 36-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot no: EL3247), on right arm via an unspecified route of administration on 27Jan2021 10:15 at single dose for covid-19 immunisation. The patient's Medical history and concomitant drug was not reported. The patient experienced sore arm on 28Jan2021 06:00. Prior to vaccination, patient was not diagnosed with COVID-19, Prior to vaccination, patient was not diagnosed with COVID-19, patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received within 2 weeks of vaccination. Outcome of the event was not recovered
Redness, swelling at injection site w/ yellow fever vaccine "throat feels swollen; tingling hands, feet" w/ oral thyroid vaccine.
A non-serious spontaneous report of a patient who received expired FLUMIST was received from a health professional concerning a five-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. On 10-Nov-2011, the nurse administered FLUMIST to the patient; she did not realize that the FLUMIST had been expired. The product had expired on 02-Nov-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event is considered resolved.
pt recvd vax & exp h/a, nausea, backache, muscle aches & extreme lethargy-couldn't swallow, difficulty breathing, lost a great deal of hair; incapitated 2 wks;
This spontaneous report as received from a healthcare student refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. In approximately 2015 (reported as "about a year ago"), the patient received an improperly stored and expired dose of ZOSTAVAX (exact dose, route of administration, anatomical location, lot # and expiration date were not provided). There were no adverse effects reported. The temperature excursion details were not provided. Additional information has been requested.